Tilvalosin (as tartrate) 25,00 g, Excipients 100.00 g.

Treatment and prevention of respiratory diseases caused by microorganisms sensitive to Tylvalosin mainly mycoplasmosis, chronic respiratory disease in poultry, swine enzootic pneumonia, swine dysentery and porcine ileitis. Tylvalosin is a new macrolide antibiotic of high efficacy, up to ten times stronger than Tylosin, resulting antimycoplasmal this superior efficacy. Tylvax® provides faster absorption, better bioavailability and in higher concentrations than those achievable with tylosin, ensuring a specific wide area distribution for pulmonary airways and blood.